|
Insider Trading: Acadia Pharmaceuticals Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acadia Pharmaceuticals Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Acadia Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Acadia Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is ACAD.
The reporting company's CIK number is 1070494.
The total value of stock buying since 2005 is $8,930,093.
The total value of stock sales is $3,557,867.
The total value of stock exercises is $169,528.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Acadia Pharmaceuticals Inc (ACAD) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Acadia Pharmaceuticals Inc (ACAD) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Acadia Pharmaceuticals Inc (ACAD).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 0 | 0 | 32,000 | 0 |
| 2008-03 | 0 | 0 | 0 | 0 | 4,000 | 8,800 |
| 2008-02 | 0 | 0 | 8,000 | 86,906 | 18,000 | 21,640 |
| 2007-12 | 0 | 0 | 30,500 | 374,136 | 18,500 | 89,105 |
| 2007-11 | 0 | 0 | 8,000 | 89,740 | 5,000 | 5,400 |
| 2007-09 | 0 | 0 | 20,518 | 312,533 | 6,518 | 43,083 |
| 2007-08 | 0 | 0 | 16,000 | 248,896 | 0 | 0 |
| 2007-05 | 0 | 0 | 35,000 | 451,486 | 0 | 0 |
| 2006-12 | 0 | 0 | 0 | 0 | 3,000 | 1,500 |
| 2006-08 | 0 | 0 | 8,000 | 64,000 | 4,000 | 0 |
| 2006-05 | 0 | 0 | 24,000 | 256,080 | 0 | 0 |
| 2006-03 | 0 | 0 | 40,000 | 654,290 | 0 | 0 |
| 2006-02 | 0 | 0 | 12,000 | 181,200 | 0 | 0 |
| 2006-01 | 0 | 0 | 20,000 | 200,480 | 0 | 0 |
| 2005-12 | 0 | 0 | 20,000 | 195,840 | 0 | 0 |
| 2005-09 | 0 | 0 | 40,000 | 442,280 | 0 | 0 |
| 2005-04 | 1,312,506 | 8,930,093 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Acadia Pharmaceuticals Inc (ACAD)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-21 | Iversen Leslie L (Director) | Option Exercise | 2,000 | .00 | 0 |
| 2008-08-06 | Hacksell Uli (CEO) | Option Exercise | 20,000 | .00 | 0 |
| 2008-03-18 | Rasmussen Torsten (Director) | Option Exercise | 4,000 | 2.20 | 8,800 |
| 2008-02-14 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Option Exercise | 5,000 | 1.08 | 5,400 |
| 2008-02-13 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 8,000 | 10.86 | 86,906 |
| 2008-02-13 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Option Exercise | 8,000 | 1.08 | 8,640 |
| 2008-02-11 | Iversen Leslie L (Director) | Option Exercise | 1,000 | 1.20 | 1,200 |
| 2008-02-05 | Kaplan Lester J Ph D (Director) | Option Exercise | 4,000 | 1.60 | 6,400 |
| 2007-12-07 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Option Exercise | 2,000 | 1.08 | 2,160 |
| 2007-12-06 | Lundstrom Brian (Sr. VP, Bus. Devt.) | Sale | 12,500 | 12.03 | 150,406 |
| 2007-12-06 | Lundstrom Brian (Sr. VP, Bus. Devt.) | Option Exercise | 12,500 | 6.61 | 82,625 |
| 2007-12-06 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 4,000 | 12.02 | 48,100 |
| 2007-12-06 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Option Exercise | 4,000 | 1.08 | 4,320 |
| 2007-12-06 | Hacksell Uli (CEO) | Sale | 14,000 | 12.54 | 175,630 |
| 2007-11-15 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Option Exercise | 5,000 | 1.08 | 5,400 |
| 2007-11-14 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 8,000 | 11.22 | 89,740 |
| 2007-09-20 | Lundstrom Brian (Sr. VP, Bus. Devt.) | Sale | 1,418 | 16.08 | 22,808 |
| 2007-09-20 | Lundstrom Brian (Sr. VP, Bus. Devt.) | Option Exercise | 1,418 | 6.61 | 9,372 |
| 2007-09-12 | Lundstrom Brian (Sr. VP, Bus. Devt.) | Sale | 5,100 | 16.02 | 81,685 |
| 2007-09-12 | Lundstrom Brian (Sr. VP, Bus. Devt.) | Option Exercise | 5,100 | 6.61 | 33,711 |
| 2007-09-04 | Hacksell Uli (CEO) | Sale | 14,000 | 14.86 | 208,040 |
| 2007-08-15 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 16,000 | 15.56 | 248,896 |
| 2007-05-16 | Hacksell Uli (CEO) | Sale | 35,000 | 12.90 | 451,486 |
| 2006-12-11 | Iversen Leslie L (Director) | Option Exercise | 3,000 | .50 | 1,500 |
| 2006-08-24 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 8,000 | 8.00 | 64,000 |
| 2006-08-24 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Option Exercise | 4,000 | .00 | 0 |
| 2006-05-18 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 16,000 | 10.67 | 170,720 |
| 2006-03-20 | Brann Mark R (President & CSO) | Sale | 26,000 | 15.82 | 411,320 |
| 2006-03-17 | Brann Mark R (President & CSO) | Sale | 14,000 | 17.36 | 242,970 |
| 2006-02-15 | Aasen Thomas H (Vice Pres., CFO, Treas. & Sec.) | Sale | 12,000 | 15.10 | 181,200 |
| 2006-01-06 | Brann Mark R (CSO) | Sale | 6,000 | 10.08 | 60,480 |
| 2006-01-05 | Brann Mark R (CSO) | Sale | 7,500 | 10.00 | 75,000 |
| 2006-01-04 | Brann Mark R (CSO) | Sale | 3,000 | 10.00 | 30,000 |
| 2006-01-03 | Brann Mark R (CSO) | Sale | 3,500 | 10.00 | 35,000 |
| 2005-12-20 | Brann Mark R (CSO) | Sale | 20,000 | 9.79 | 195,840 |
| 2005-09-16 | Brann Mark R (CSO) | Sale | 40,000 | 11.06 | 442,280 |
| 2005-04-20 | Van Osch Martien (Director) | Purchase | 366,501 | 6.79 | 2,488,541 |
| 2005-04-20 | Gordon Carl L (Director) | Purchase | 359,603 | 6.79 | 2,441,704 |
| 2005-04-20 | Walton Alan G (10% Owner) | Purchase | 586,402 | 6.82 | 3,999,848 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Acadia Pharmaceuticals Inc (symbol ACAD,
CIK number 1070494) see
the Securities and Exchange Commission (SEC) website.
|
|
